Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical...
The REVEL trial studied 1,200 non-small cell lung cancer patients to see if the drug Cyramza (ramucirumab) improved overall surival. The doctors had...
The REVEL trial studied 1,200 non-small cell lung cancer patients to see if the drug Cyramza (ramucirumab) improved overall surival. The doctors had...
The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side...
The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side...
Hi Everyone, I'm feeling really lost, worried, and petrified at the moment. 4th September my mum (Helen 66) came into my house and said she would need...
Hello all It is time again for some advice from this wonderful and knowledgeable team. What is the efficiency of Alimta to cross the BBB ? I read that...
Is there any data/evidence that the combination of Alimta and Xalkori would give promising results without significant side effects? My daughter has...
Is there a standard for using PET scans rather than CT scans for surveillance? I have had 9 PET scans since my diagnosis in May 2015 of ALK positive...
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.